<code id='C9A691E8EA'></code><style id='C9A691E8EA'></style>

<acronym id='C9A691E8EA'></acronym>

<center id='C9A691E8EA'><center id='C9A691E8EA'><tfoot id='C9A691E8EA'></tfoot></center><abbr id='C9A691E8EA'><dir id='C9A691E8EA'><tfoot id='C9A691E8EA'></tfoot><noframes id='C9A691E8EA'>

<optgroup id='C9A691E8EA'><strike id='C9A691E8EA'><sup id='C9A691E8EA'></sup></strike><code id='C9A691E8EA'></code></optgroup>

<b id='C9A691E8EA'><label id='C9A691E8EA'><select id='C9A691E8EA'><dt id='C9A691E8EA'><span id='C9A691E8EA'></span></dt></select></label></b><u id='C9A691E8EA'></u>

~~<i id='C9A691E8EA'><strike id='C9A691E8EA'><tt id='C9A691E8EA'><pre id='C9A691E8EA'></pre></tt></strike></i>~~

Home» comprehensive» explore

explore

explore

author：focus 2025-10-02 13:31:41 Page View：68

Alexis Borisy — Venture capitalist Alexis Borisy Vanessa Leroy for STAT

EQRx is done, sold for its cash.

The once-buzzy but now dormant biotech company is being acquired by Revolution Medicines, a developer of cancer drugs, the companies announced Tuesday.

advertisement

The all-stock deal is essentially a balance-sheet transfer of $1 billion in cash from EQRx to Revolution. What was left of EQRx’s drug pipeline is being shelved.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Millions may soon lose Medicaid when they don't have to
Next article： 23andMe had bad news about my health. I wish a person had delivered it

focus

Walensky prepares to leave CDC — and Congress — behind

Walensky prepares to leave CDC — and Congress — behind

OutgoingCDCDirectorRochelleWalenskyJIMWATSON/AFPviaGettyImagesRochelleWalensky,theoutgoingdirectorof

PBM reforms clear House panel

PBM reforms clear House panel

SarahSilbiger/GettyImagesWASHINGTON—PanelsinboththeHouseandSenatehavenowpassedrestrictionstodrugmidd

Drug repurposing or repositioning? The language matters

Drug repurposing or repositioning? The language matters

AdobeFindinganewmedicineisnevereasy.Butdevelopingtreatmentsforpatientswithrarediseases—conditionstha

NYU radiologists take on the challenge of expensive MRI machines

ResearchersatNYUduringahackathontobuildanMRIfromscratch.CourtesyNYUHowmanyscientistsdoesittaketobuil

read more